Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Pancreas Cancer, Pancreas Cyst
Interventions: Lateral Flow Assay (LFA); Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 17 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Head and Neck Cancer
Interventions: erlotinib hydrochloride, protein analysis, western blotting, immunohistochemistry staining method, laboratory biomarker analysis, liquid chromatography, mass spectrometry, neoadjuvant therapy, therapeutic conventional surgery; Drug · Genetic · Other + 1 more
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 120 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Central Nervous System Tumors, Brain Tumors
Interventions: Gallium-67 Citrate (Ga-67), In-111 DTPA (In-111 pentetate); Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 2 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Failure
Interventions: The Optimal Lymph FLow (TOLF), Daily Monitoring; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Sepsis
Interventions: Fluid Resuscitation, Standard of Care; Other
Lead sponsor: Cheetah Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 12
States / cities: Birmingham, Alabama • Sacramento, California • Denver, Colorado + 7 more

Conditions: Burns, Hemofiltration, Kidney Failure, Acute, Shock, Septic
Interventions: An FDA approved continuous renal replacement device, Control Group; Device · Other
Lead sponsor: American Burn Association; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 9
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Tampa, Florida + 6 more

Conditions: Pressure Ulcer
Interventions: Fluid Immersion Simulation System, Air Fluidized Bed System; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rare Cancers, Cholangiocarcinoma, Cancer of Unknown Primary Site
Interventions: FoundationOne CDx and FoundationOne Liquid CDx; Diagnostic Test
Lead sponsor: TargetCancer Foundation; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Vaccine Preventable Disease
Interventions: COVID-19 Vaccination; Biological
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Sleep
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Substance-related Disorders, HIV Risk Behavior
Interventions: Therapeutic Workplace, Methadone, Buprenorphine; Behavioral · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Pelvic Pain Syndrome
Interventions: Amniotic suspension allograft; Biological
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Heart Failure
Interventions: Medtronic Pacemaker; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Type1diabetes
Interventions: Artificial Pancreas Controller in Dual Hormone Mode, Artificial Pancreas Controller in Single Hormone Mode, Artificial Pancreas Controller in Predictive Low Glucose Suspend Mode, XeriSol glucagon; Device · Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 50 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Lymphoma
Interventions: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Dexamethasone, Autologous Tumor Cell-Based Vaccine, IL-2; Drug · Biological
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Dural Sealing
Interventions: DuraSeal Exact Spine Sealant System, Control; Device · Other
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 924 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 36
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 31 more

Conditions: Influenza
Interventions: fluID Rapid Influenza Test; Device
Lead sponsor: Nanogen, Inc.; Industry
Eligibility: Not listed
Enrollment: 1,300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 12
States / cities: San Diego, California • DeLand, Florida • Shreveport, Louisiana + 8 more

Conditions: Supracondylar Humerus Fracture
Interventions: Acetaminophen-Hydrocodone, Acetaminophen and Ibuprofen; Drug
Lead sponsor: Le Bonheur Children's Hospital; Other
Eligibility: 4 Years to 13 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Adrenal Gland Pheochromocytoma, Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma, Childhood Kidney Neoplasm, Childhood Langerhans Cell Histiocytosis, Childhood Mature Teratoma, Congenital Mesoblastic Nephroma, Desmoid Fibromatosis, Ganglioneuroma, Lymphoproliferative Disorder, Malignant Neoplasm, Malignant Solid Neoplasm, Melanocytic Neoplasm, Myeloproliferative Neoplasm, Neoplasm of Uncertain Malignant Potential, Neuroendocrine Neoplasm, Stromal Neoplasm
Interventions: Cytology Specimen Collection Procedure, Medical Chart Review; Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 25 Years
Enrollment: 75,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2030
U.S. locations: 246
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 177 more

Conditions: Cardiac Output, Low, Pediatric
Interventions: NICOM by Cheetah Medical; Device
Lead sponsor: Indiana University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Endocrine Disorders of Female Reproductive System
Interventions: collect body fluids/tissues & med history; Procedure
Lead sponsor: University of Tennessee; Other
Eligibility: 8 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung, KEAP1 Gene Mutation, NRF2 Mutation, NFE2L2 Gene Mutation
Interventions: Not listed
Lead sponsor: Calithera Biosciences, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 63
States / cities: Daphne, Alabama • Mobile, Alabama • Glendale, Arizona + 52 more

Conditions: Ovarian Cancer
Interventions: Blood-Based Ovarian Cancer Screening Test; Diagnostic Test
Lead sponsor: Mercy BioAnalytics, Inc.; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 1,750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Waltham, Massachusetts • Austin, Texas

Conditions: Parkinson Disease
Interventions: Procedure/Surgery: Biofluid samplings; Procedure
Lead sponsor: Michael J. Fox Foundation for Parkinson's Research; Other
Eligibility: 30 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Chicago, Illinois • Boston, Massachusetts • Portland, Oregon + 2 more

Search by objective public record fields.

ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

Lymphatic System Stimulation in Heart Failure

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis

Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)

Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

COVID-19 Antibody Levels After Vaccines

Synovial Fluid Sleep Study

Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution

Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy

Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate

Three Way Crossover Closed Loop Study With Xeris Glucagon

Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma

DuraSeal Exact Spine Sealant System Post-Approval Study

Prospective Evaluation of the Fluid Rapid Influenza Test

NSAIDs vs Opioids for Post-op Pain in Supracondylar Humerus Fractures

Project: Every Child for Younger Patients With Cancer

Non-Invasive Cardiac Output Monitor in Children

Tissue Samples and Bodily Fluid Specimens Banking

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Safety in Ovarian Cancer for Average-Risk Women - Analysis

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)